Immunohistochemical evaluation of p53 and Ki-67 proteins in colorectal adenomas;Avaliação imunoistoquímica das proteínas p53 e Ki-67 em adenomas colorretais

Arquivos de Gastroenterologia

Volumn 49, Issue 1, 2012, Pages 35-40

  de Sousa, Walysson Alves Tocantins ^a   Rodrigues, Lusmar Veras ^a   da Silva, Raimundo Gerônimo ^a   Vieira, Fernando Lopes ^a  

^a Federal University of Ceará   (Brazil)

Author keywords

Colorectal neoplasm; Immunohistochemistry; Ki67 antigen; Tumor suppressor protein p53

Indexed keywords

BIOTIN; EOSIN; FORMALDEHYDE; HEMATOXYLIN; KI 67 ANTIGEN; PHOSPHATE BUFFERED SALINE; PROTEIN P53; STREPTAVIDIN;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLONOSCOPY; COLORECTAL ADENOMA; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; POLYPECTOMY; PROTEIN EXPRESSION; RECTUM ADENOMA; RECTUM POLYP;

EID: 84859529797     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032012000100007     Document Type: Article

References (33)

1. Brenner H, Hoffmeister M, Haug U. Should colorectal cancer screening start at same age in European countries? Contributions from descriptive epidemiology. Br J Cancer. 2008;99:532-5.
2. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M; Italian Multicenter Study Group. Efficacy in standard clinical pratice of colonoscopic polipectomy in reducing colorectal cancer incidence. Gut. 2001;48:812-5.
3. Enomoto T, Kuranami M, Kakita A. Variations in the expression of platelet-derived endothelial cell growth factor in human colorectal polyps. Surg Today. 2000;30:711-7.
4. Fearon ER, Volgelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-67.
5. Grizzle WE, Myers RB, Manne U, Srivastava S. Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia. In: Hanausek M, Walaszek Z, editors. Methods in molecular medicine-tumor marker protocols. Totowa: Humana Press; 1998. p.143-60.
6. Horiuchi H, Kawamata H, Omotehara F, Fujii S, Fujimori T, Kuroda Y. Negative immunohistochemical staining of p53 protein does not always reflect wild-type p53 gene in cancer cells. J Gastroenterol. 2004;39:801-3.
7. Instituto Nacional do Câncer. Estimativa 2010 Incidência de câncer no Brasil. Rio de Janeiro: INCA, 2010. Available at: http://www.inca.gov.br
8. Isobe M, Emmanuel BS, Givol D, Oren M, Crocen CM. Localization of gene for human p53 tumor antigen to band 17p13. Nature. 1986;320:84-5.
9. Loeve F, Boer R, Zauber AG, Van Ballegooijen M, Van Oortmarssen GJ, Winamer SJ, Habbema JD. National polyp study data: evidence for regression of adenomas. Int J cancer. 2004;111: 633-9.
10. Lustosa SA, Logullo A, Artigiani R, Saad SS, Goldenberg A, Matos D. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma. Acta Cir Bras. 2005;20:353-7.
11. Mansmann U, Crispin A, Henschel V, Adrion C, Augustin V, Birkner B, Munte A. Epidemiology and quality of control of 245 000 outpatient colonoscopies. Dtsch Arztebl Int. 2008;105:434-40.
12. Matos LL, Machado LN, Sugiyama MM, Bozzetti RM, Pinhal AS. Technology applied to the detection of tumor markers. Arq Med ABC. 2005;30:19-25.
13. May P, May E. Twenty years of p53 research: structural and functions aspects of the protein. Oncogene. 1999;18:7621-738.
14. Miller C, Mohandas T, Wolf D, Prokocimer M, Rotter V, Koeffler HP. Human p53 gene localized to short arm of chromosome 17. Nature. 1986;319:783-4.
15. Muneyuki T, Watanabe M, Yamanaka M, Isaji S, Kawarada Y, Yatani R. Combination analysis of genetic alterations and cell proliferation in small intestinal carcinomas. Dig Dis Sci. 2000;45:2022-8.
16. Neves LR, Oshima CT, Artingiani-Neto R, Yanaguibashi G, Lourenço LG, Forones NM. Ki67 and p53 in gastrointestinal stromal tumors GIST. Arq Gastroenterol. 2009;46:116-20.
17. Nomura M, Watari J, Yokota K, Saitoh Y, Obara T, Kohgo Y. Morphogenesis of nonpolypoid colorectal adenomas and early carcinomas assessed by cell proliferation and apoptosis. Virchows Arch. 2000;437:17-24.
18. Petroianu A, Alberti LR, de Lima DC, Hauter HL, Rodrigues KC, Mendes JC [Colonoscopic findings in asymptomatic people]. Arq Gastroenterol. 2009;46:173-8.
19. Porcelli B, Frosi B, Arezzini L, Marinello E, Vernillo R, De Martino A, Vatti R, Minacci C. Expression of p185 and p53 in benign and malignant colorectal lesions. Histochem J. 2001;33:51-7.
20. Radovanovic-Dinic B, Nagorni A, Katic V, Satmenkovic I, Zlatic A. An immunohistochemical study of Ki-67 in colorectal adenoma. Med Arh. 2009;63:16-8.
21. Santos Jr JCM. Ano-rectal-colic cancer. Current Issues II Colorectal cancer Risk factors and prevention. Rev Bras Coloproctol. 2007;27:459-73.
22. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311-22.
23. Shanmugam C, Katkoori VR, Jhala NC, Grizzle WE, Siegal GP, Manne U. p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior. J Histochem cytochem. 2008;56:305-12.
24. Sheikh RA, Min BH, Yasmeen S, Teplitz R, Tesluk H, Ruebner BH, Tobi M, Hatfield J, Fligiel S, Lawson MJ. Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas. Dig Dis Sci. 2003;48:223-9.
25. Shinozaki M, Watanabe T, Kubota Y, Sawada T, Nagawa H, Muto T. High proliferative activity is associated with diysplasia in ulcerative colitis. Dis Colon Rectum. 2000;43:34-9.
26. Soussi T, Caron de Fromentel C, May P. Structural aspects of p53 protein in relation to gene evolution. Oncogene. 1990;5:5945-52.
27. Sugai T, Habano W, Uesugi N, Jiao Y, Nakamura S, Sato K, Chiba T, Ishii M. Molecular validation of the modified Vienna classification of colorectal tumors. J Mol Diagn. 2002;4:191-200.
28. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, desregulation and therapeutic targets in cancer. Cell Prolif. 2003; 36:131-49.
29. Vernillo R, Lorenzi B, Banduccci T, Minacci C, Vindigni C, Lucenti Fei A, Lorenzi M. Immunohistochemical expression of p53 and ki67 in colorectal adenomas and prediction of malignancy and development of new polyps. Int J Biol Markers. 2008;23:89-95.
30. Voskuil DW, Kampman E, van Geloof W, Grubben M, Kok F, Van Muijen G, Nagengast F, Vasen H, Van't Veer P. No major difference in K-ras and p53 abnormalities in sporadic and hereditary nonpolyposis colorectal adenomas. Dig Dis Sci. 2000;45:2187-94.
31. Watatani M, Ieda S, Kuroda K, Inui H, Nishimura K, Yasutomi M. Comparison of p53 and bcl-2 expression in initial, synchronous, and metachronous colorectal adenomas. Surg Today. 1999:29:707-12.
32. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982;23:835-42.
33. Yonish-Rouach E. A question of lie or death: the p53 tumor suppressor gene. Pathol Biol. 1997;45:815-23.